Kura
Develops targeted cancer medicines led by KOMZIFTI for genetically defined AML.
$12.70
After-hours close+0.06 (+0.47%)
At close$12.64(−4.10%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 99.75%Insiders 2.06%
Institutions and insiders are filed separately and overlap, so together they can pass the whole company. No split is drawn from them.
Shares outstanding 88.77M · Float 86.00M · 96.9% free float
Institutions13F, as of Jun 30, 2026
226 holders · 88.55M shares · 30 new positions · 123 increased · 62 reduced · 30 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 10.51M | 11.84% | +871.7K | Aug 7, 2026 |
| Suvretta Capital Management, LLC | 8.58M | 9.66% | 0 | Aug 14, 2026 |
| BVF Inc/IL | 8.45M | 9.51% | 0 | Aug 14, 2026 |
| State Street Corp | 5.33M | 6.00% | +817.3K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 3.92M | 4.41% | +130.5K | Aug 13, 2026 |
| Armistice Capital, LLC | 3.68M | 4.14% | −58.0K | Aug 14, 2026 |
| AQR Capital Management LLC | 3.13M | 3.52% | +1.00M | Aug 14, 2026 |
| Goldman Sachs Group Inc | 2.27M | 2.55% | +831.7K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 9.40% | 7.56M | 13G | May 2, 2025 ↗ |
| BlackRock, Inc. | 7.80% | 6.33M | 13G | Apr 17, 2025 ↗ |
| Armistice Capital, LLC | 7.14% | 6.20M | 13G | Aug 15, 2025 ↗ |
| State Street Corporation | 5.70% | 4.93M | 13G | Feb 9, 2026 ↗ |
| Peter Kolchinskyincl. RA Capital Management, L.P., RA Capital Healthcare Fund, L.P. +1 more | 5.60% | 4.37M | 13G | Dec 5, 2024 ↗ |
| Biotechnology Value Fund L P | 5.10% | 4.42M | 13G | Nov 14, 2025 ↗ |
| Vanguard Capital Management | 5.01% | 4.43M | 13G | Apr 30, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Troy Edward Wilson | director, officer: President and CEO | 914.7K | 1.03% | Aug 24, 2026 |
| Teresa Brophy Bair | officer: Chief Legal Officer | 195.4K | 0.22% | Aug 21, 2026 |
| Mollie Leoni | officer: Chief Medical Officer | 182.3K | 0.21% | Jun 22, 2026 |
| Brian T. Powl | officer: Chief Commercial Officer | 169.3K | 0.19% | Aug 24, 2026 |
| Kathleen Ford | officer: Chief Operating Officer | 153.6K | 0.17% | May 20, 2026 |
| Thomas James Doyle | officer: SVP, Finance & Accounting | 145.2K | 0.16% | Jan 27, 2026 |
| Francis Burrows | officer: Chief Scientific Officer | 32.4K | 0.04% | Jan 27, 2026 |
| Faheem Hasnain | director | 24.0K | 0.03% | Dec 10, 2025 |
| Thomas Malley | director | 10.0K | 0.01% | Mar 20, 2026 |
1 ten-percent owner holds 4.41M shares by Form 4, outside the officers-and-directors figure above · 9 people have not refiled in the last 18 months (542.7K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 24, 2026 | Troy Edward Wilsondirector, officer: President and CEO | Purchase | 100,000 | $12.39 | 479,194 |
| Aug 21, 2026 | Brian T. Powlofficer: Chief Commercial Officer | Sale | 4,345 | $11.89 | 169,269 |
| Aug 19, 2026 | Teresa Brophy Bairofficer: Chief Legal Officer | Sale | 31,487 | $12.63 | 195,444 |
| Aug 17, 2026 | Troy Edward Wilsondirector, officer: President and CEO | Purchase | 100,000 | $11.12 | 379,194 |
| Jun 18, 2026 | Mollie Leoniofficer: Chief Medical Officer | Sale | 84,929 | $9.82 | 182,345 |
| May 21, 2026 | Brian T. Powlofficer: Chief Commercial Officer | Sale | 10,000 | $11.00 | 173,614 |
| May 18, 2026 | Teresa Brophy Bairofficer: Chief Legal Officer | Sale | 2,256 | $9.38 | 226,931 |
| May 19, 2026 | Kathleen Fordofficer: Chief Operating Officer | Sale | 2,257 | $9.08 | 153,560 |
| May 19, 2026 | Brian T. Powlofficer: Chief Commercial Officer | Sale | 339 | $9.21 | 183,614 |
| Jan 27, 2026 | Teresa Brophy Bairofficer: Chief Legal Officer | Sale · 3 lots | 11,208 | $8.46 | 226,931 |
CongressHouse and Senate disclosures
Not reported.